Ascentage Pharma Group International
HKEX:6855.HK
38.8 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| -523.286 | -402.351 | -476.19 | -406.734 | -405.742 | -376.682 | -358.429 | -319.177 | -847.399 | -633.315 | -228.424 | -116.883 | -86.327 | -86.327 | -29.629 | -29.629 | -29.629 | -26.96 | -26.96 | -26.96 |
| Depreciation & Amortization
| 45.23 | 45.576 | 29.872 | 31.044 | 13.005 | 14.521 | 12.756 | 13.733 | 13.357 | 12.436 | 9.748 | 8.399 | 4.616 | 4.616 | 3.125 | 3.125 | 3.125 | 0.387 | 0.387 | 0.387 |
| Deferred Income Tax
| 0 | 0 | -10.622 | 0 | 37.868 | 0 | 0 | 0 | 0 | 0 | -30.361 | -13.663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 13.254 | 18.249 | 16.528 | 5.577 | 20.03 | 26.941 | 40.609 | 33.418 | 68.179 | 2.643 | 27.575 | 6.894 | 6.894 | 6.894 | 0 | 0 | 0 | 16.248 | 16.248 | 16.248 |
| Change In Working Capital
| -69.012 | 0 | 104.373 | 0 | -74.911 | 0 | -55.251 | 0 | 3.457 | 0 | 24.892 | -10.144 | 6.77 | 6.77 | 2.633 | 2.633 | 2.633 | 0.537 | 0.537 | 0.537 |
| Accounts Receivables
| -91.537 | 0 | -0.388 | 0 | -53.968 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| -6.719 | 0 | -5.518 | 0 | -3.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 29.244 | 0 | 110.279 | 0 | -17.013 | 0 | -55.251 | 0 | 3.457 | 0 | 24.892 | -10.144 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 176.201 | -29.938 | 6.703 | 34.912 | 196.514 | -18.355 | 48.977 | -26.592 | 519.288 | 401.049 | 45.519 | 1.651 | 8.631 | 8.631 | -3.126 | -3.126 | -3.126 | -1.685 | -1.685 | -1.685 |
| Operating Cash Flow
| -357.613 | -368.464 | -318.714 | -335.201 | -251.104 | -353.575 | -311.338 | -298.618 | -243.118 | -217.187 | -120.69 | -116.977 | -59.417 | -59.417 | -26.996 | -26.996 | -26.996 | -11.473 | -11.473 | -11.473 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| -12.133 | -33.975 | -91.845 | -111.443 | -222.173 | -213.242 | -120.726 | -129.195 | -60.406 | -17.05 | -9.122 | -5.135 | -12.365 | -12.365 | -5.134 | -5.134 | -5.134 | -0.843 | -0.843 | -0.843 |
| Acquisitions Net
| -20 | 0 | -20 | 0 | -20 | 0 | 0 | 0 | 0 | 0 | 29.979 | -33.378 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -486.531 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 456.552 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 118.829 | -30.799 | -130.166 | -31.158 | 780.123 | -791.23 | 220.311 | -77.757 | -103.619 | -20.258 | 56.256 | 284.187 | 12.365 | 12.365 | 5.134 | 5.134 | 5.134 | 0.843 | 0.843 | 0.843 |
| Investing Cash Flow
| 86.696 | -64.774 | -242.011 | -142.601 | 537.95 | -1,004.472 | 99.585 | -206.952 | -164.025 | -37.308 | 47.134 | 245.674 | -12.365 | -12.365 | -5.134 | -5.134 | -5.134 | -0.843 | -0.843 | -0.843 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| 0 | -120.365 | 0 | -467.192 | 0 | -123.738 | 0 | -197.069 | 0 | -61.093 | -8.75 | -48.372 | -12.5 | -12.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 108.07 | 0.004 | 0.004 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -12.305 | 0 | -26.776 | 0 | -25.874 | 0 | 0 | 0 | 0 | 0 | 0 | -75.592 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -77.216 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -74.578 | 575.999 | 198.287 | -19.435 | 730.856 | 952.667 | 846.622 | -3.688 | 385.3 | -4.031 | 792.436 | 94.947 | 12.496 | 12.496 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| -86.883 | 455.634 | 171.511 | 447.757 | 704.982 | 1,076.405 | 846.622 | 193.381 | 385.3 | 57.062 | 792.436 | 67.727 | -32.552 | -32.552 | -29.575 | -29.575 | -29.575 | 70.794 | 70.794 | 70.794 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 5.857 | 21.956 | 44.184 | 13.828 | -21.591 | -1.688 | -43.633 | 1.946 | -0.069 | 1.243 | 20.797 | 6.166 | 5.288 | 5.288 | -8.222 | -8.222 | -8.222 | 0.754 | 0.754 | 0.754 |
| Net Change In Cash
| -351.943 | 44.352 | -345.03 | -16.217 | 970.237 | -283.33 | 591.236 | -310.243 | -21.912 | -196.19 | -32.665 | 213.706 | 235.567 | 235.567 | -69.927 | -69.927 | -69.927 | 59.232 | 59.232 | 59.232 |
| Cash At End Of Period
| 1,038.048 | 1,389.991 | 1,345.639 | 1,690.669 | 1,706.886 | 736.649 | 1,019.979 | 428.743 | 738.986 | 760.898 | 184.747 | 217.411 | 239.272 | 239.272 | 3.705 | 3.705 | 3.705 | 73.632 | 73.632 | 73.632 |